None Too Rare
Published on
Some diseases affect only a small number of people, and yet CHOP’s commitment to researching and treating them is huge.
Published on
Some diseases affect only a small number of people, and yet CHOP’s commitment to researching and treating them is huge.
Published on
The center offers evaluation, diagnosis, treatment, and follow-up care for children with this life-threatening condition.
Published on
CHOP’s groundbreaking expertise in treating children with congenital hyperinsulinism (HI) began more than 50 years ago and draws patients from all over the world.
Published on
Leaders of the HI Center at CHOP remember two decades of advancements in care for children with HI.
Published on
Children with congenital hyperinsulinism (HI) may be at risk for exocrine pancreatic insufficiency, which affects the ability of the pancreas to function properly.
Published on
Two generations of the Parkes family have come to Children’s Hospital of Philadelphia for treatment for hyperinsulinism (HI). They’ve seen and experienced breakthroughs in HI care firsthand.
Published on
Diva D. De León-Crutchlow, MD, MSCE, will assume the role as Chief of the Division of Endocrinology and Diabetes at Children’s Hospital of Philadelphia, effective July 1.
Published on
Our HI team has been busy continuing to pave the way to improve the diagnosis, treatment and outcomes for children with hyperinsulinism through discovery and innovation.
Published on
Patients share their experiences of growing up with HI during the 2016 Congenital Hyperinsulinism Family Conference in Philadelphia.
Published on
Charles A. Stanley, MD, received the Judson J. Van Wyk Prize, the most prestigious award given by the Pediatric Endocrine Society.